论文部分内容阅读
目的:分析研讨吲达帕胺联合氨氯地平片在高血压合并冠心病疾病治疗中的临床疗效。方法:此研究为前瞻性研究,采用随机抽签方式从我院2013年2月-2015年5月期间收治的高血压合并冠心病疾病者中,抽取212例纳入到讨论中,按入院单双顺序分106例研究组(吲达帕胺+氨氯地平片治疗)和106例对照组(硝苯地平控释片治疗),对比两组治疗效果。结果:研究组治疗总疗效92.45%比对照组79.24%高,组间数据有统计学意义(P<0.05)。对比两组患者治疗后三酰甘油、DBP、SBP指数,研究组比对照组优,组间数据有统计学意义(P<0.05),但对比治疗前各指数,组间数据无统计学意义(P>0.05)。结论:临床治疗高血压合并冠心病疾病可将吲达帕胺和氨氯地平片联合使用,疗效突出,各体征指数控制明显,推广应用价值高。
Objective: To analyze the clinical efficacy of indapamide combined with amlodipine in the treatment of hypertension complicated with coronary heart disease. METHODS: This study was a prospective study of randomized draws taken from our hospital from February 2013 to May 2015 were admitted to hypertensive patients with coronary heart disease, 212 cases were included in the discussion, according to admission single and double order 106 cases of study group (indapamide + amlodipine treatment) and 106 cases of control group (nifedipine controlled release tablets treatment), the two groups were compared. Results: The total effective rate of the study group was 92.45% higher than that of the control group (79.24%). There was significant difference between the two groups (P <0.05). Comparing the two groups of patients after treatment triglyceride, DBP, SBP index, the study group than the control group, the data between the groups was statistically significant (P <0.05), but compared to the index before treatment, the data between the groups was not statistically significant P> 0.05). Conclusion: The combination of indapamide and amlodipine can effectively treat hypertension and coronary heart disease. The curative effect is obvious, the control of each index is obvious, and the value of popularization and application is high.